RT Journal Article
SR Electronic
T1 Childhood Ocular Inflammation Sensations and Symptoms Reporting Questionnaire (ChOIR-Q): Development and assessment of a paediatric self-report tool
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.06.24305169
DO 10.1101/2024.04.06.24305169
A1 Solebo, Ameenat L
A1 Kellett, Salomey
A1 Rahi, Jugnoo
A1 Dick, Andrew D
A1 Ashworth, Jane
A1 Cooper, Gisella
A1 McLoone, Eibhlin
A1 Muthusamy, Kirithika
A1 Pilling, Rachel
A1 Petrushkin, Harry
A1 Tadic, Valerija
YR 2024
UL http://medrxiv.org/content/early/2024/04/09/2024.04.06.24305169.abstract
AB We aimed to develop and assess age-appropriate child and young person, self and proxy report tools to capture and characterise eye symptoms in childhood ocular inflammatory disease.Children and young people aged under 18 years diagnosed with inflammatory eye disease (uveitis), and their families, were recruited to a multiphase study, involving: text and pictogram items generation through focus groups and interviews (Phase 1), pre-testing face validity analysis including and discussion amongst a multidisciplinary professional panel (Phase 2), and pre-piloting (Phase 3) and piloting (Phase 4) of the instrument amongst a representative sample of the target population.A total of 170 participants, comprising 113 children/young people and 57 parents/carers, were recruited. Phase 1 resulted in the generation of 60 items. Following phases 2 to 3, these items were developed into self-completion, and assisted self-completion tools for children aged 9 years and older, and those aged under 9 years respectively, and a proxy score, for completion by parents and carers. Correlations scores between individual item and whole domain scoring were above 0.58 for the self-completion tools and above 0.39 for the proxy completion tool. Initial Cronbach’s alpha for the tool overall was good at 0.84, with within-domain alphas of 0.81 – 0.87.In conclusion, these instruments demonstrate the feasibility of capturing ocular sensations in children and young people, with a patient centred development approach resulting in tools with high rates of completion, and acceptable internal instrument consistency.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institute for Health and Care Research (NIHR Clinician Scientist award CS-2018-18-ST2-005)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The London - Queen Square Research Ethics Committee (REC reference 19/LO/0729) gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesIndividual level data are not being made available for this study involving human research participant data. Consent for publication of raw data was not obtained (as this approach may have led to differential non-inclusion of certain patient groups). The dataset could in theory pose a threat to confidentiality. Guidance was sought from relevant Ethics Committee.